The financial arrangement for the global Phase III program in common warts, where by Verrica and Torii split the cost of the program with the first $40 million funded by Torii has unlocked the ...

Background Cervical cancer is one of the leading causes of death among women in Africa, but stigma often delays cervical ...

The Student Council of Gowanda High School named eight outstanding Panthers as Students of the Month for October. Honorees ...

Core FFO was negative $10.5 million, reflecting continued financial pressure and ongoing challenges in operating results.

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicine, announced today the publication of foundational research demonstrating the power of its proprietary ...

Katelynne Williams, of Newcastle High School, is The Oklahoman's Student of the Week.

Spectrum segment revenue and adjusted EBITDA declined by $800,000 and $700,000, respectively, due to "the termination of ...

Asset Coverage Ratio: The ratio defined under the Investment Company Act of 1940, measuring the level of coverage over a ...

Good morning, everyone, and welcome to Poste Italiane Third Quarter and 9 Months 2025 Results Conference Call. Shortly, our CEO, Matteo Del Fante, will take you through some opening remarks, and then ...

Katapult Holdings, Inc. (NASDAQ: KPLT) Q3 2025 Earnings Call Transcript November 12, 2025 Katapult Holdings, Inc. beats ...

Progressing Phase 2 studies for ratutrelvir, a ritonavir-free, protease inhibitor regimen in development for Acute and Long ...

Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...